Takeshi Onda
About
In The Last Decade
Takeshi Onda
65 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 108
- Molecular Biology 550
- Oncology 261
- Pulmonary and Respiratory Medicine 175
- Biomaterials 168
- Biomedical Engineering 154
Countries citing papers authored by Takeshi Onda
This map shows the geographic impact of Takeshi Onda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Onda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Onda more than expected).
Fields of papers citing papers by Takeshi Onda
This network shows the impact of papers produced by Takeshi Onda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Onda. The network helps show where Takeshi Onda may publish in the future.
Co-authorship network of co-authors of Takeshi Onda
This figure shows the co-authorship network connecting the top 25 collaborators of Takeshi Onda. A scholar is included among the top collaborators of Takeshi Onda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeshi Onda. Takeshi Onda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 12 | |
| 5 | 16 | |
| 6 | Effects of Topical Hangeshashinto (TJ-14) on Chemotherapy-Induced Oral Mucositis | 1 |
| 7 | 3 | |
| 8 | 10 | |
| 9 | 1 | |
| 10 | 53 | |
| 11 | 1 | |
| 12 | 97 | |
| 13 | 23 | |
| 14 | Marked antitumor activity of NK012, 7-ethyl-10-hydroxycamptothecin-incorporating micellar nanoparticle, in liver metastatic tumor model of colorectal cancer | 1 |
| 15 | Superior antitumor activity of NK012, 7-ethyl-10-hydroxycamptothecin-incorporating micellar nanoparticle, to irinotecan | 3 |
| 16 | 56 | |
| 17 | 3 | |
| 18 | 11 | |
| 19 | 22 | |
| 20 | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.